Vulnerability of patients with chronic obstructive pulmonary disease according to gender in China

International Journal of COPD

Volumn 7, Issue , 2012, Pages 825-832

  Lou, Peian ^a   Zhu, Yanan ^b   Chen, Peipei ^a   Zhang, Pan ^a   Yu, Jiaxi ^a   Zhang, Ning ^a   Zhang, Lei ^a   Wu, Hongmin ^b   Zhao, Jing ^b   Chen, Na ^a  

^a Center for Disease Control and Prevention of Xuzhou City   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Chronic obstructive pulmonary disease; Gender; Vulnerability

Indexed keywords

ANTIBIOTIC AGENT; BIOFUEL; THEOPHYLLINE;

ADULT; AGED; ARTICLE; CHINA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE EXACERBATION; EXERCISE; FAMILY HISTORY; FEMALE; HEALTH BEHAVIOR; HEALTH CARE COST; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; QUESTIONNAIRE; SEX DIFFERENCE; SMOKING; SOCIAL SUPPORT; VULNERABLE POPULATION;

AGED; BRONCHODILATOR AGENTS; CHI-SQUARE DISTRIBUTION; CHINA; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DISEASE SUSCEPTIBILITY; DRUG COSTS; FEMALE; HUMANS; INCOME; LIFE EXPECTANCY; LIFE STYLE; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; RURAL HEALTH; SEX DISTRIBUTION; SEX FACTORS; SMOKING; THEOPHYLLINE; TIME FACTORS;

EID: 84872329604     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S37447     Document Type: Article

References (29)

1. Global initiative for chronic obstructive pulmonary disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011_Jan21.pdf. Accessed November 6, 2012.
2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442.
3. World Health Organisation. The Global Burden of Disease: 2004 update. 2008. Available from: http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/index.html. Accessed November 6, 2012.
4. Chan-Yeung M, Aït-Khaled N, White N, Ip MS, Tan WC. The burden and impact of COPD in Asia and Africa. Int J Tuberc Lung Dis. 2004;8:2-14.
5. Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China - a large population based spirometry based cross-sectional survey. Am J Respir Crit Care Med. 2007;176: 753-760.
6. Bureau of Disease Prevention and Control, Ministry of Health of the People's Republic of China, Chinese Center for Disease Prevention and Control. Report on chronic disease in China; 2006:5.
7. Xiaocong F, Xiangdong W, Chunxue B. Burden and importance of proper management about chronic obstructive pulmonary disease in China. Int J Respir. 2011;31:493-497.
8. Fanchen F, Yifeng Y, Gangwen C. Application of vulnerability apprais-ing in constructing theoretical model for early warning of emergent public health event. Acad J Sec Med Univ. 2007;28:116-119.
9. Jinchun C, Aimin W, Feng W. The construction of emergency mecha-nism and assessment system of emergency public health even. China Inspection and Quarantine. 2007;20:25-26. Chinese.
10. Pixin R, Chen W, Wanzhen Y, et al. The risk factors for chronic obstruc-tive pulmonary disease in females in Chinese rural areas. Chin J Inert Med. 2006;45:974-979.
11. Lou P, Zhu Y, Chen PP, et al. Vulnerability, beliefs, treatments and economic burden of chronic obstructive pulmonary disease in rural areas in China: a cross-sectional study. BMC Public Health. 2012; 12:287.
12. Jones PW. Quality of life measurement for patients with disease of the airways. Thorax. 1991;46:676-682.
13. Partridge MR, van der Molen T, Myrseth SE, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med. 2006;6:13.
14. Yingyun C, Zuozhe L, Zongjun F. Living quality evaluation of the patients of chronic obstructive pulmonary disease. Chin J Gen Pract. 2004;3:225-227.
15. Centers for Disease Control. Years of potential life lost before ages 65 and 85, United States, 1989-1990. MMWR Morb Mortal Wkly Rep. 1992;41:313-315.
16. Eisner MD, Anthonisen N, Coultas D, et al. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182:693-718.
17. Quanying H, Yanliang M, Rongbao Z, Ruihong Y, Xinli M. Study on the epidemiological difference of four kinds of chronic respiratory diseases in the urban and rural areas of China. Chin J Epidemiol. 2006;27:459-460.
18. Peian L, Peipei C, Jiaxi Y, Lei L, Ning Z, Jingde L. A descriptive study on the smoking pattern among general population in Xuzhou, 2008. Chin J Epidemiol. 2010:286-289.
19. Carrasco-Garrido P, Miguel-Díez JD, Rejas-Gutierrez J, et al. Characteristics of chronic obstructive pulmonary disease in Spain from a gender perspective. BMC Pulm Med. 2009;9:2.
20. Nihlen U, Nyberg P, Montnemery P, Löfdahl CG. Influence of family history and smoking habits on the incidence of self-reported physician's diagnosis of COPD. Respir Med. 2004;98:263-270.
21. Zhou Y, Hu G, Wang D, et al. Community based integrated interven-tion for prevention and management of chronic obstructive pulmonary disease (COPD) in Guangdong, China: cluster randomised controlled trial. BMJ. 2010;341:c6387.
22. Tashkin DP. Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety. Curr Opin Pulm Med. 2010; 16:97-105.
23. Miravitlles M. Prevention of exacerbations of COPD with pharmaco-therapy. Eur Respir Rev. 2010;19:119-126.
24. Barr RG, Celli BR, Mannino DM, et al. Comorbidities, patient knowl-edge, and disease management in a national sample of patients with COPD. Am J Med. 2009;122:348-355.
25. Restrepo RD, Alvarez MT, Wittnebel LD, et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis. 2008;3:371-384.
26. Dalal AA, Christensen L, Fang Liu F, Riedel AA. Direct costs of chronic obstructive pulmonary disease among managed care patients. Int J Chron Obstruct Pulmon Dis. 2010;5:341-349.
27. Fei X, Yaqiong L, Hongbing S, Yaochu X. Years of potential life lost of chronic obstructive pulmonary diseases among residents in Nanjing from 1997 to 2005. Chin J Epidemiol. 2007;28:230204.
28. Laurin C, Lavoie KL, Bacon SL, et al. Sex differences in the prevalence of psychiatric disorders and psychological distress in patients with chronic obstructive pulmonary disease. Chest. 2007;132:148-155.
29. An L, Lin YX, Yang T, et al. Predictive validity of BODE index for anxious and depressive symptoms in patients with chronic obstructive pulmonary disease. Chin Med J (Engl). 2010;123:1845-185l.